Dr. Keller, an assistant professor of medicine at Baltimore-based Johns Hopkins Hospital, will use the funds to further her research into risk of central venous catheters complications among patients self-administering IV antibiotics in their homes.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Patients who self-administer parenteral antimicrobial therapy via catheters, known as outpatient parenteral antimicrobial therapy, are at risk from numerous catheter-based complications, such as central line-associated bloodstream infection and adverse drug events.
Dr. Keller’s research will focus on studying why these complications occur and how to prevent them by examining how patients and their caregivers actually perform the therapy.
The funding is part of SHEA’s Epi Project Competition. Dr. Keller will receive up to $20,000.
More articles on healthcare quality:
Drug abuse fueling syphilis outbreak in Oklahoma
Michigan health officials confirm first measles case in state this year
3.5M doses of yellow fever vaccine sent to Brazil
